Affirm climbs as Morgan Stanley hikes price target to $90

AFRMAFRM

Affirm shares are higher Monday, March 30, 2026 as investors react to a fresh analyst note that lifted Morgan Stanley’s price target to $90 from $70 while keeping an Equal-Weight rating. The move extends a recent rebound in high-beta fintech after Affirm’s latest GMV and outlook commentary helped stabilize sentiment.

1. What’s moving the stock

Affirm Holdings (AFRM) is trading higher today as the market digests a new Wall Street catalyst: Morgan Stanley raised its price target on the stock to $90 from $70 while maintaining an Equal-Weight rating. Investors are treating the higher target as a near-term sentiment boost for a name that has been volatile amid shifting expectations around BNPL growth, credit performance, and funding costs. (tipranks.com)

2. Why it matters

A price-target hike from a major bank can be enough to move a high-beta fintech even without a same-day company press release, particularly when the stock is already in a rebound phase. The adjustment reinforces the view that Affirm’s recent operating performance and GMV trajectory have been resilient enough for analysts to re-rate the setup despite ongoing macro sensitivity. (tradingview.com)

3. What to watch next

Traders will be watching whether follow-on analyst actions emerge and whether the stock can hold gains into the next round of company updates and macro data that influence consumer credit and funding conditions. With Affirm’s shares historically reacting sharply to both rates and risk appetite, any shift in market expectations for inflation and policy could quickly amplify or reverse today’s move. (cdn3.benzinga.com)